These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 20809482

  • 1. Bio-creep in non-inferiority clinical trials.
    Everson-Stewart S, Emerson SS.
    Stat Med; 2010 Nov 30; 29(27):2769-80. PubMed ID: 20809482
    [Abstract] [Full Text] [Related]

  • 2. Non-parametric assessment of non-inferiority with censored data.
    Freitag G, Lange S, Munk A.
    Stat Med; 2006 Apr 15; 25(7):1201-17. PubMed ID: 16345041
    [Abstract] [Full Text] [Related]

  • 3. A comparison of multiple testing procedures for the gold standard non-inferiority trial.
    Röhmel J, Pigeot I.
    J Biopharm Stat; 2010 Sep 15; 20(5):911-26. PubMed ID: 20721781
    [Abstract] [Full Text] [Related]

  • 4. On non-inferiority analysis based on delta-method confidence intervals.
    Rothmann MD, Tsou HH.
    J Biopharm Stat; 2003 Aug 15; 13(3):565-83. PubMed ID: 12921402
    [Abstract] [Full Text] [Related]

  • 5. The ABC of non-inferiority margin setting from indirect comparisons.
    Julious SA.
    Pharm Stat; 2011 Aug 15; 10(5):448-53. PubMed ID: 21928354
    [Abstract] [Full Text] [Related]

  • 6. TACT method for non-inferiority testing in active controlled trials.
    Wang SJ, Hung HM.
    Stat Med; 2003 Jan 30; 22(2):227-38. PubMed ID: 12520559
    [Abstract] [Full Text] [Related]

  • 7. Detecting and accounting for violations of the constancy assumption in non-inferiority clinical trials.
    Koopmeiners JS, Hobbs BP.
    Stat Methods Med Res; 2018 May 30; 27(5):1547-1558. PubMed ID: 27587591
    [Abstract] [Full Text] [Related]

  • 8. Covariate effect on constancy assumption in noninferiority clinical trials.
    Xu S, Barker K, Menon S, D'Agostino RB.
    J Biopharm Stat; 2014 May 30; 24(6):1173-89. PubMed ID: 25036666
    [Abstract] [Full Text] [Related]

  • 9. Choice of delta noninferiority margin and dependency of the noninferiority trials.
    Tsong Y, Zhang J, Levenson M.
    J Biopharm Stat; 2007 May 30; 17(2):279-88. PubMed ID: 17365224
    [Abstract] [Full Text] [Related]

  • 10. Some fundamental issues with non-inferiority testing in active controlled trials.
    James Hung HM, Wang SJ, Tsong Y, Lawrence J, O'Neil RT.
    Stat Med; 2003 Jan 30; 22(2):213-25. PubMed ID: 12520558
    [Abstract] [Full Text] [Related]

  • 11. A note on the conservativeness of the confidence interval approach for the selection of non-inferiority margin in the two-arm active-control trial.
    Sankoh AJ.
    Stat Med; 2008 Aug 30; 27(19):3732-42. PubMed ID: 18407575
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
    Tsong Y, Zhang J.
    J Biopharm Stat; 2007 Aug 30; 17(2):247-57. PubMed ID: 17365221
    [Abstract] [Full Text] [Related]

  • 13. Choosing the analysis population in non-inferiority studies: per protocol or intent-to-treat.
    Matilde Sanchez M, Chen X.
    Stat Med; 2006 Apr 15; 25(7):1169-81. PubMed ID: 16397861
    [Abstract] [Full Text] [Related]

  • 14. Strength of evidence of non-inferiority trials-The adjustment of the type I error rate in non-inferiority trials with the synthesis method.
    Kang SH, Tsong Y.
    Stat Med; 2010 Jun 30; 29(14):1477-87. PubMed ID: 20535762
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A covariate-adjustment regression model approach to noninferiority margin definition.
    Nie L, Soon G.
    Stat Med; 2010 May 10; 29(10):1107-13. PubMed ID: 20209669
    [Abstract] [Full Text] [Related]

  • 17. Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials.
    Wang SJ, Hung HM, Tsong Y, Cui L.
    Stat Med; 2001 Jul 15; 20(13):1903-12. PubMed ID: 11427948
    [Abstract] [Full Text] [Related]

  • 18. Assessment of blinding in clinical trials.
    Bang H, Ni L, Davis CE.
    Control Clin Trials; 2004 Apr 15; 25(2):143-56. PubMed ID: 15020033
    [Abstract] [Full Text] [Related]

  • 19. Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo.
    Pigeot I, Schäfer J, Röhmel J, Hauschke D.
    Stat Med; 2003 Mar 30; 22(6):883-99. PubMed ID: 12627407
    [Abstract] [Full Text] [Related]

  • 20. Testing for qualitative interactions between stages in an adaptive study.
    Parker RA.
    Stat Med; 2010 Jan 30; 29(2):210-8. PubMed ID: 19908261
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.